Account Executive

Oncology Account Executive Join a team of brilliant, passionate innovators determined to transform healthcare. Our scientists, engineers, sales executives, and visionaries are united by an unwavering commitment to changing the standard of care in prenatal and cancer diagnostics. This is where cutting-edge science meets human compassion, and every innovation you contribute helps remove the fear of the unknown from some of life's most critical medical moments. If you're driven by purpose, energized by innovation, and ready to help shape the future of precision medicine at scale, this is where you belong. We are looking for a field-based professional Oncology Account Executive, Milwaukee with scientific and clinical expertise to support our oncology portfolio of liquid biopsy products. The position is responsible for driving sales volume for BillionToOne's Northstar Liquid biopsy products and services, while cultivating relationships with oncologists and other members of the extended cancer care community in the designated geography. The Oncology Account Executive is a field based position and reports to a Regional Manager
- Oncology. Increasing revenue and driving market development through direct sales to individual Oncologists Sales efforts include effective prospecting and cultivating new business and maintaining key relationships Bachelor's Degree or equivalent experience Demonstrated successful sales track record (e.g., Experience selling to medical providers Experience selling medical diagnostics, medical or surgical devices Lives within the defined territory and centrally located to defined accounts Commitment to travel within defined territory Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required Exceptionally bright, flexible, self-motivated and results oriented with strong interpersonal and analytical skills and the ability to think strategically as well as execute tactically Ability to assess the needs of medical professionals and staff members with a focus on consultative sales, coordination of logistics, and problem solving Working alongside brilliant, kind, passionate and dedicated colleagues, in an empowering environment, toward a global vision, striving for a future in which transformative molecular diagnostics can help millions of patients Multiple medical benefit options; Retirement savings program including a 4% Company match Latest and greatest hardware (laptop, lab equipment, facilities) At BillionToOne, we are proud to offer a combination of a (1) base pay + uncapped commissions (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave, etc.). We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. Our revolutionary QCT molecular counting technology enhances disease detection resolution by over a thousandfold using cell-free DNA, a breakthrough that has already transformed the lives of over half a million patients worldwide. Unity Complete is the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne's Fetal Cell Capture Technology. Our Northstar liquid biopsy test uniquely combines treatment selection with real-time monitoring, giving oncologists unprecedented precision in cancer care. In 2025, we completed one of the most successful IPOs for a medical diagnostics company, building on nearly $400M in private funding, including our $130M Series D in 2024 and backed by world-class investors including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. Headquartered in Menlo Park with facilities in Union City, CA, and a new lab opening in Austin, TX in 2027, we're continuing to push the boundaries of what's possible in molecular diagnostics. Ready to help us change the world, one molecule at a time?